EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 51 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,022,101 | +1.8% | 200,208 | 0.0% | 0.05% | +18.2% |
| Q3 2022 | $1,986,000 | +1.4% | 200,208 | 0.0% | 0.04% | 0.0% |
| Q2 2022 | $1,958,000 | +100.6% | 200,208 | +99.8% | 0.04% | +76.0% |
| Q1 2022 | $976,000 | +0.5% | 100,208 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $971,000 | +0.2% | 100,208 | 0.0% | 0.02% | -10.7% |
| Q3 2021 | $969,000 | +128.0% | 100,208 | +127.8% | 0.03% | +133.3% |
| Q2 2021 | $425,000 | – | 43,998 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |